NEWPORT BEACH, CA -- (Marketwire) -- 06/19/12 -- Silverberg Surgical and Medical Group is announcing the recent addition of an innovative approach to wrinkle reduction. LAVIV is the first and only personalized cell therapy designed to improve the appearance of wrinkles by capitalizing on the natural benefits of a patient's own collagen. Recently FDA approved, only a handful of board-certified dermatologists and plastic surgeons, including Dr. Nancy Silverberg, have completed the comprehensive training required by LAVIV manufacturer Fibrocell Science, Inc. Additionally, Dr. Silverberg is one of few physicians certified to train other physicians to perform the LAVIV technique.
At her Newport Beach dermatology practice, Dr. Silverberg says many patients are concerned about the appearance of wrinkles and aging skin. Additionally, she says her patients express concern over the safety and effectiveness over the growing number of skincare products and services available. However, when discussing the LAVIV process with her patients, Dr. Silverberg says the fact that the injections are created from the patient's own collagen producing cells eases some of this concern.
The Newport Beach dermatologist says collagen helps give skin its tone, structure, and overall quality. However, as people age, she says collagen production decreases and the cells break down, resulting in wrinkles and a loss of skin tone. LAVIV uses a patented technology to extract a patient's fibroblast cells, which are responsible for producing collagen. The cells gathered from a small skin sample are then returned to the lab and multiplied, resulting in the formation of new fibroblast cells, which are then injected into the smile lines of the patient. In addition to the FDA approved method for correcting smile lines, Dr. Silverberg also notes that they use LAVIV to treat other lines such as scars, as well as sun-damaged skin, both of which are treatments currently being studied by the FDA.
Dr. Silverberg says the recommended treatment plan for LAVIV is a series of three treatments, typically three to six weeks apart. Because each injection is developed from a patient's own cells, she says there is less chance for an allergic reaction. Dr. Silverberg adds that the wrinkle treatment is an exciting development in the dermatologic industry, and speaks to the commitment her and her colleagues have made in the pursuit of improving patient safety and satisfaction.
About Nancy L. Silverberg, MD
After earning her undergraduate degree from Cornell University, and her medical degree from the St. Louis University School of Medicine, Dr. Nancy Silverberg completed an Internal Medicine residency training at the University of Arizona, and a Dermatology residency training at the University of California, Irvine. She is currently an associate clinical professor of Dermatology at UCI and on the medical staff at Hoag Hospital. Dr. Silverberg is board-certified in Dermatology, and is a fellow of the American Academy of Dermatology and the American Society for Mohs Surgery.
Silverberg Surgical and Medical Group is located at 1401 Avocado Ave., Ste. 703, Newport Beach, CA 92660, and can be reached at (949) 751-6683. Dr. Silverberg and the entire medical team can also be found online at www.silverbergmd.com, or the Newport Beach Dermatology Facebook page.
|Fri, May 17, 2013|
|10:24 PM||Med BioGene Inc. Comments on Market Activity|
|09:43 PM||OneMove Announces Shareholder Approval of Amalgamation|
|07:30 PM||Pericom Semiconductor to Present at Sidoti's Semi-Annual Microcap Conference in New York City on June 7, 2013|
|07:24 PM||Mannix Completes Shares for Debt Settlement|
|07:17 PM||Robert C. Grey: Shareholder News Release|
|07:15 PM||Woulfe Mining Provides Update|
|07:11 PM||John Anderson: Shareholder News Release|
|07:10 PM||Redwood Announces Proposed Changes to Redwood Energy Income Class|
|07:06 PM||Donald Crossley: Shareholder News Release|
|07:02 PM||Western and Work Wear Retailer Boot Barn(R) Rebrands, Restocks and Refreshes Four Florida Locations|
|07:00 PM||AQM Copper Announces Adoption of Advance Notice Policy|
|06:38 PM||Avanti Receives and Will Oppose Judicial Review Application by Nisga'a Nation|
|06:27 PM||EURO Ressources Announces Date of Annual Shareholders' Meeting and Dividend Distribution|
|06:22 PM||Spy Inc. Announces CFO Transition|
|06:22 PM||/ KILL - Zayo Group|
|06:19 PM||Media Advisory: Harper Government to Make an Announcement Regarding Scientific Discovery Research|
|06:07 PM||Celebrate the Arts With the 2013 Passport to the Arts|
|05:50 PM||Northern Announces Appointment of New President & CEO|
|05:32 PM||New Reality Series Highlights Growing Social Trend of Mixed-Union Marriages|
|05:30 PM||Aurcana Corporation Clarifies Technical Disclosure|
|05:23 PM||Powerball Jackpot Increased to New Record, $600 Million|
|05:17 PM||Vemma(R) Recognized With Eight Awards in Two Prestigious Competitions|
|05:06 PM||Jackson Walker Wins Twin Anti-SLAPP Victories for Dallas Better Business Bureau|
|05:00 PM||Magnum Hunter Resources Reports Receipt of NYSE MKT Notice Relating to Previously-Disclosed Late Filings of 2012 Form 10-K and First Quarter 2013 Form 10-Q|
|05:00 PM||Cott Announces TSX Approval of Renewal of Normal Course Issuer Bid|
|04:57 PM||Dundee Corporation Declares Quarterly First Preference Shares, Series 1 Dividend|
|04:57 PM||Dundee Corporation Declares Quarterly First Preference Shares, Series 2 Dividend|
|04:56 PM||Qualstar Names Board Positions|
|04:55 PM||StrikeForce Technologies Releases Its First Quarter 2013 10Q Financial Results|
|04:51 PM||Xylitol Canada Inc. Financial Results for Three Months Ended March 31, 2013|
|More Press Releases From Marketwired News Releases|